Clinical Trial Update: A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase study to assess the safety and feasibility of combining nivolumab with drug-eluting bead transarterial chemoembolization for hepatocellular carci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Liver Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING